O'Boyle C J, deBeaux A C, Watson D I, Ackroyd R, Lafullarde T, Leong J Y, Williams J A R, Jamieson G G
University of Adelaide, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia 5000, Australia.
Surg Endosc. 2002 Apr;16(4):620-5. doi: 10.1007/s00464-001-8218-3. Epub 2002 Jan 9.
Helium is an inert gas that, if used for insufflation during laparoscopy, may be followed by less postoperative pain than carbon dioxide (CO2) insufflation, due to a more limited effect on intraabdominal pH and metabolism. Saline lavage has also recently been shown to reduce postoperative pain following laparoscopic surgery. To evaluate these possibilities and to better define the clinical safety of helium insufflation, we undertook a prospective randomized trial comparing CO2 and helium insufflation with or without saline lavage in patients undergoing elective laparoscopic upper abdominal surgery.
From January to November 2000, 173 patients undergoing elective laparoscopic cholecystectomy or fundoplication were randomized to undergo laparoscopy with either CO2 or helium insufflation. Within each group, patients were further randomized to undergo peritoneal lavage with 2 L of 0.9% saline at the end of the surgical procedure. This yielded the following four patient groups; CO2 (group 1, n = 47), CO2 + saline lavage (group 2, n = 43), helium (group 3, n = 43) and helium + saline lavage (group 4, n = 40). Patients were blinded to their randomization, and post-operative assessment was also performed by a blinded investigator, who applied a standardized scoring system to assess postoperative pain.
The study groups were well matched for age, sex, weight, American Society of Anesthesiologists (ASA) status, duration of surgery, and volume of gas utilized, and 81% of patients were discharged within 48 h. There were no differences in the incidence of postoperative complications among the study groups, and postoperative pain scores were not significantly different when all four groups were compared. When helium (groups 3 and 4) was compared with CO2 (groups 1 and 2), no differences in pain score were seen. When no lavage (groups 1 and 3) was compared with lavage (groups 2 and 4), less pain was found in the group undergoing saline peritoneal lavage (mean 4-h pain score, 5.9 vs 5.2; 24-h pain score, 4.8 vs 4.1; p > 0.05).
The use of helium insufflation for laparoscopic surgery, while not associated with any significant adverse sequelae, was not associated with less postoperative pain in this trial. The use of saline peritoneal lavage was associated with less pain in the early postoperative period.
氦是一种惰性气体,在腹腔镜检查期间若用于气腹,由于其对腹腔内pH值和代谢的影响较为有限,术后疼痛可能比二氧化碳(CO₂)气腹更少。最近也有研究表明,生理盐水灌洗可减轻腹腔镜手术后的疼痛。为评估这些可能性并更好地界定氦气腹的临床安全性,我们进行了一项前瞻性随机试验,比较在接受择期腹腔镜上腹部手术的患者中,使用CO₂气腹和氦气腹并联合或不联合生理盐水灌洗的效果。
2000年1月至11月,173例接受择期腹腔镜胆囊切除术或胃底折叠术的患者被随机分为两组,分别接受CO₂气腹或氦气腹的腹腔镜检查。在每组中,患者在手术结束时进一步被随机分为两组,一组接受2L 0.9%生理盐水的腹腔灌洗。这样就产生了以下四组患者:CO₂组(第1组,n = 47)、CO₂ + 生理盐水灌洗组(第2组,n = 43)、氦气组(第3组,n = 43)和氦气 + 生理盐水灌洗组(第4组,n = 40)。患者对其分组情况不知情,术后评估也由一位不知情的研究者进行,该研究者应用标准化评分系统评估术后疼痛。
各研究组在年龄、性别、体重、美国麻醉医师协会(ASA)分级、手术时长和气体使用量方面匹配良好,81%的患者在48小时内出院。各研究组术后并发症的发生率无差异,比较所有四组时,术后疼痛评分也无显著差异。将氦气组(第3组和第4组)与CO₂组(第1组和第2组)进行比较时,疼痛评分未见差异。将未灌洗组(第1组和第3组)与灌洗组(第2组和第4组)进行比较时,发现接受生理盐水腹腔灌洗的组疼痛较轻(平均4小时疼痛评分,5.9对5.2;24小时疼痛评分,4.8对4.1;p > 0.05)。
在本试验中,腹腔镜手术使用氦气腹虽未出现任何显著的不良后果,但也未减少术后疼痛;使用生理盐水腹腔灌洗与术后早期疼痛减轻相关。